Physician

Stephen Soloway, M.D.,FACP.,FACR.,CCD

According to 2025 Medicare claims, Stephen Soloway, M.D., FACP., FACR., CCD (NPI: 1609997873) practices rheumatology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is ARTHRITIS & RHEUMATOLOGY ASSOCIATES OF SOUTH JERSEY PC (NPI: 1255344594; TIN: 223452730) and primary practice location at 08360-7042.

Soloway's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 705 traditional Medicare patients, billed 341,767 HCPCS/CPT codes, and received $4,574,699 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,351 prescription claims across 249 beneficiaries totaling $1,225,176 in drug costs, led by Remicade (Infliximab). 2022 DME data shows 17 claims. Open Payments data shows 45 records totaling $5,798. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,091,725 and ending at $1,225,176. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,464 to $638.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,307	135,719	$4,813,992
2016	1,437	184,123	$6,351,947
2017	1,212	223,161	$6,610,009
2018	972	227,313	$5,932,229
2019	729	236,747	$5,548,565
2020	741	238,787	$4,832,581
2021	735	284,096	$5,070,538
2022	702	280,399	$4,904,160
2023	640	246,179	$3,988,851
2024	705	341,767	$4,574,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	690	4,665	$1,091,725
2016	589	3,264	$992,825
2017	474	2,367	$1,159,550
2018	357	1,976	$1,399,772
2019	313	1,765	$1,022,029
2020	319	1,876	$1,024,611
2021	321	1,861	$1,305,411
2022	309	1,513	$1,431,507
2023	295	1,287	$1,620,455
2024	249	1,351	$1,225,176

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	32	71	$216,667
2016	87	111	$269,717
2017	80	103	$260,025
2018	58	58	$57,906
2019	12	12	$9,359
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	17	$284
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	262	1,354	$99
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	190	298	$46
77080	Dxa bone density measurement of hip, pelvis, spine	276	276	$38
G0008	Administration of influenza virus vaccine	160	161	$34
96415	Administration of chemotherapy into vein, each additional hour	159	1,183	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Remicade	Infliximab	54	1,864	$465,575
Simponi Aria	Golimumab	22	1,102	$188,158
Cimzia (2 Pack)	Certolizumab Pegol	23	644	$134,484
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	336	$65,573
Benlysta	Belimumab	13	364	$31,211

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$5,798	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephen Soloway, M.D., FACP., FACR., CCD?

Tedicare shows public-source Medicare data for Stephen Soloway, M.D., FACP., FACR., CCD (NPI 1609997873), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Soloway, M.D., FACP., FACR., CCD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen Soloway, M.D., FACP., FACR., CCD?

Stephen Soloway, M.D., FACP., FACR., CCD is linked to ARTHRITIS & RHEUMATOLOGY ASSOCIATES OF SOUTH JERSEY PC (billing NPI 1255344594) in the available physician profile data.

Does Stephen Soloway, M.D., FACP., FACR., CCD have Open Payments data?

Stephen Soloway, M.D., FACP., FACR., CCD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.